The global botanical extract market, specifically the Root Green (Traditional Chinese Medicine) sector, has undergone a massive paradigm shift. No longer confined to traditional apothecary shops, high-quality herbal roots and granules are now integral components of the multi-billion dollar wellness, nutraceutical, and pharmaceutical industries worldwide. As of 2024, the demand for standardized TCM granules has seen a CAGR of over 12.5%, driven by a global shift toward natural and holistic healthcare solutions.
Manufacturers in China, specifically those like Neo-Green Herbs, are at the epicenter of this evolution. By combining 5,000 years of herbal wisdom with contemporary biotechnology, we have successfully transformed raw "Root Green" materials into precision-engineered granules that offer higher bioavailability, consistent active ingredients, and zero chemical contaminants.
Modern practitioners in Europe, North America, and Southeast Asia are increasingly moving away from "raw herb boiling" toward concentrated granules. The primary trends include:
Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques.
We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
International procurement managers from pharmaceutical companies and wellness chains often face challenges in sourcing consistent, safe, and legal herbal extracts. The procurement requirements have evolved to focus on three critical pillars:
Our products are applied across various professional settings:
Located in the "Medicine Treasury" of China, our Sichuan base provides unique access to the world's most potent herb species grown in ideal high-altitude environments.
With assets over 30 billion RMB and 5,000+ employees, we offer the supply chain stability that small-scale traders simply cannot match.
Our "Green Cycle" concept integrates planting, extraction, and eco-friendly waste management, ensuring a sustainable future for the TCM industry.
Our Quality Assurance team employs advanced testing equipment and methodologies to monitor all stages of production, guaranteeing the authenticity, potency, purity, and consistency of our herbal medicines. Furthermore, we continuously invest in research and development to innovate while preserving the integrity of ancient TCM practices.
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation, especially in the field of TCM granules, which enjoys a high reputation. As a “National Enterprise Technology Center”, “High-tech Enterprise” and “National Key Leading Enterprise in Agricultural Industrialization”, NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
NGP is a large-scale enterprise with more than 5,000 employees and total assets of more than 30 billion RMB. We have planned 300+ production bases across Jiangxi, Yunnan, and Chongqing.
Built a nationwide sales network and exported to major global markets. We utilize smart e-commerce and professional B2B channels to ensure global reach.
If you are interested in our products, contact us today for high-quality pharmaceutical supply chain solutions for practitioners and clinics worldwide.
Neo-Green Herbs
